139 related articles for article (PubMed ID: 18250989)
1. Fluorine-18-labeled 5-fluorouracil is a useful radiotracer for differentiation of malignant tumors from inflammatory lesions.
Sugae S; Suzuki A; Takahashi N; Minamimoto R; Cheng C; Theeraladanon C; Endo I; Togo S; Inoue T; Shimada H
Ann Nucl Med; 2008 Jan; 22(1):65-72. PubMed ID: 18250989
[TBL] [Abstract][Full Text] [Related]
2. Biological evaluation of 3-[(18)F]fluoro-α-methyl-D-tyrosine (D-[(18)F]FAMT) as a novel amino acid tracer for positron emission tomography.
Ohshima Y; Hanaoka H; Tominaga H; Kanai Y; Kaira K; Yamaguchi A; Nagamori S; Oriuchi N; Tsushima Y; Endo K; Ishioka NS
Ann Nucl Med; 2013 May; 27(4):314-24. PubMed ID: 23337966
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and radiation dosimetry of [¹⁸F]-5-fluorouracil.
Hino-Shishikura A; Suzuki A; Minamimoto R; Shizukuishi K; Oka T; Tateishi U; Sugae S; Ichikawa Y; Horiuchi C; Inoue T
Appl Radiat Isot; 2013 May; 75():11-7. PubMed ID: 23416442
[TBL] [Abstract][Full Text] [Related]
4. Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation.
van Waarde A; Jager PL; Ishiwata K; Dierckx RA; Elsinga PH
J Nucl Med; 2006 Jan; 47(1):150-4. PubMed ID: 16391199
[TBL] [Abstract][Full Text] [Related]
5. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model.
Liu RS; Chou TK; Chang CH; Wu CY; Chang CW; Chang TJ; Wang SJ; Lin WJ; Wang HE
Nucl Med Biol; 2009 Apr; 36(3):305-12. PubMed ID: 19324276
[TBL] [Abstract][Full Text] [Related]
7. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.
van Waarde A; Cobben DC; Suurmeijer AJ; Maas B; Vaalburg W; de Vries EF; Jager PL; Hoekstra HJ; Elsinga PH
J Nucl Med; 2004 Apr; 45(4):695-700. PubMed ID: 15073267
[TBL] [Abstract][Full Text] [Related]
8. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and 18F-FLT.
Zhao S; Kuge Y; Kohanawa M; Takahashi T; Zhao Y; Yi M; Kanegae K; Seki K; Tamaki N
J Nucl Med; 2008 Jan; 49(1):135-41. PubMed ID: 18077525
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Bioevaluation of Novel [
Yang X; Wang F; Zhu H; Yang Z; Chu T
Mol Pharm; 2019 May; 16(5):2118-2128. PubMed ID: 30964298
[TBL] [Abstract][Full Text] [Related]
11. Kinetic modeling of 5-fluorouracil anabolism in colorectal adenocarcinoma: a positron emission tomography study in rats.
Bading JR; Yoo PB; Fissekis JD; Alauddin MM; D'Argenio DZ; Conti PS
Cancer Res; 2003 Jul; 63(13):3667-74. PubMed ID: 12839957
[TBL] [Abstract][Full Text] [Related]
12. Comparative uptake of ¹⁸F-FEN-DPAZn2, ¹⁸F-FECH, ¹⁸F-fluoride, and ¹⁸F-FDG in fibrosarcoma and aseptic inflammation.
Liang X; Tang G; Wang H; Hu K; Tang X; Nie D; Sun T; Huang T
Appl Radiat Isot; 2014 Aug; 90():158-64. PubMed ID: 24751349
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG.
Pellegrino D; Bonab AA; Dragotakes SC; Pitman JT; Mariani G; Carter EA
J Nucl Med; 2005 Sep; 46(9):1522-30. PubMed ID: 16157536
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T
J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of FET and FDG for differentiating lung carcinoma from inflammation in mice.
Chang CH; Wang HE; Wu SY; Fan KH; Tsai TH; Lee TW; Chang SR; Liu RS; Chen CF; Chen CH; Fu YK
Anticancer Res; 2006; 26(2A):917-25. PubMed ID: 16619487
[TBL] [Abstract][Full Text] [Related]
16. Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
Hellwig D; Menges M; Schneider G; Moellers MO; Romeike BF; Menger MD; Kirsch CM; Samnick S
Nucl Med Biol; 2005 Feb; 32(2):137-45. PubMed ID: 15721759
[TBL] [Abstract][Full Text] [Related]
17. [(18)F]-labeled 2-methoxyphenylpiperazine derivative as a potential brain positron emission tomography imaging agent.
Mou T; Yang W; Peng C; Zhang X; Ma Y
Appl Radiat Isot; 2009 Nov; 67(11):2013-8. PubMed ID: 19679486
[TBL] [Abstract][Full Text] [Related]
18. Tetraphenylphosphonium as a novel molecular probe for imaging tumors.
Min JJ; Biswal S; Deroose C; Gambhir SS
J Nucl Med; 2004 Apr; 45(4):636-43. PubMed ID: 15073261
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice.
McLarty K; Moran MD; Scollard DA; Chan C; Sabha N; Mukherjee J; Guha A; McLaurin J; Nitz M; Houle S; Wilson AA; Reilly RM; Vasdev N
Nucl Med Biol; 2011 Oct; 38(7):953-9. PubMed ID: 21982567
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]